Physicians Give Positive Feedback on ChatGPT as Diagnostic Aid
Korean doctors have expressed their positive feedback on generative artificial intelligence model ChatGPT when used in the medical field. However, the physicians believe its use should only be limited to assisting in diagnosis and prescription. The reason behind this is that there is not yet enough basis to trust the medical information acquired by ChatGPT, according to a recent survey conducted by InterMD Company, a knowledge- and information-sharing community platform exclusive for physicians.
The poll results showed that 56.8 percent of respondents gave positive answers to using ChatGPT in medical fields. However, the doctors believe that it should be used only as a diagnostic and prescription aid. The survey was conducted from April 25 to 26, with a 95 percent confidence rate and plus and minus 1.25 percent sampling error, and one-thousand-and-eight physicians participated.
Among the reasons cited by the doctors who responded positively were reducing workload as it can perform repetitive jobs, curtailing decision-making time by analyzing various clinical data, and simplifying the treatment process. Meanwhile, 13.5 percent were negative about using ChatGPT in medical fields, citing too low medical evidence and reliability to be used in this area as the most common reason.
ChatGPT is an AI model specialized in language, developed by OpenAI, a US developer, and released on December 1, 2020. The surveyed doctors said they knew about this technology, but only 38.4 percent used it. Among those who used it, 71.8 percent said they earned a satisfactory answer.
Even though the doctors see the potential of ChatGPT as a diagnostic aid, they still believe that it will be challenging for AI to replace human doctors entirely. However, machine learning can assist in some parts of the treatment patterns that can change. As machines cannot take responsibility for medical judgments, new domains will likely emerge for doctors. It is important to make continuous efforts to reduce errors in using AI technology, according to InterMD Company CEO Lee Young-do.
